THE PHYSIOLOGICAL SIGNIFICANCE OF TOTAL BODY CLEARANCE IN PHARMACOKINETIC STUDIES
- 1 March 1982
- journal article
- research article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 7 (1) , 25-30
- https://doi.org/10.1111/j.1365-2710.1982.tb00904.x
Abstract
The significance of the total body clearance (CL) is studied based on a physiological pharmacokinetic model. In the absence of evidence to the contrary, and for the sake of uniformity, it is proposed that the elimination rate of a drug at any time after various routes of dosing be assumed to be proportional to its systemic arterial plasma (blood) concentration with a proportionality constant equal to CL. The CL, calculated by the intravenous dose divided by the AUC, is defined as the hypothetical volume of the systemic arterial plasma (blood) completely cleared of drug per unit time even though the drug is eliminated by the lungs and venous plasma is assayed. A marked difference in the calculated elimination rate of lidocaine in patients based on arterial or venous plasma data is demonstrated. The calculated CLs which are sometimes greater than the cardiac output can be rationalized. The limitation of conventional multi‐compartmental mammillary modelling theory in the defining of CL is discussed.This publication has 10 references indexed in Scilit:
- Nomograms for Drug Use in Renal DiseaseClinical Pharmacokinetics, 1981
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- Potential pitfalls in the conventional pharmacokinetic studies: Effects of the initial mixing of drug in blood and the pulmonary first-pass eliminationJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Applications of a recirculatory stochastic pharmacokinetic model: Limitations of compartmental modelsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusionJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Comparison of gentamicin C1 and (C1a, C2)-levels in patientsEuropean Journal of Clinical Pharmacology, 1978
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975
- PLASMA PROTEIN BINDING OF BUPIVACAINE AND ITS INTERACTION WITH OTHER DRUGS IN MANBritish Journal of Anaesthesia, 1975
- Thiopental PharmacokineticsJournal of Pharmaceutical Sciences, 1968